(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

AZAD

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: Estados Unidos

Snapshot rápido

AZAD

ST13

US500000079215450

Classe

35, 39, 40, 42, 44, 45

Pedido

79215450

Registro

5450649

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

17/05/2025

Tipo de marca

Mista

Classes Nice

35, 39, 40, 42, 44, 45

Data de depósito

01/06/2017

Data de registro

24/04/2018

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

06/09/2024

Última transação

17/05/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

25

Localização do titular

Schaffhausen, CH

Examinador

AVENT, TEAGUE

Localização atual

Historical data usage

Descrição da marca

The mark consists of the stylized wording "AZAD". The first letter "A" is stylized such that its bottom creates an image of a stylized leaf in negative space. The second letter "A" is stylized such that its bottom creates an image of a stylized Greek cross in negative space.

Titulares e representantes

Titulares

AZAD Pharma AG
AZAD Pharmaceutical Ingredients AG

Representantes

Stacey Halpern Knobbe, Martens, Olson & Bear, LLP

Classificação técnica

Classes Nice

Classe 35Classe 39Classe 40Classe 42Classe 44Classe 45

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 35

Commercial consultancy and assistance before authorizing authorities

Classe 39

Transport of pharmaceutical products; Warehousing servicespackagingstorage and distribution of pharmaceutical products

Classe 40

Custom synthesis and manufacturing of active pharmaceutical ingredientsintermediates thereof and finished dosage formsespecially for pharmaceutical use

Classe 42

Scientific and technological servicesresearch and design in the field of pharmaceuticals and active pharmaceutical ingredients; scientific and technological consultancy in the field of pharmaceuticalsrendering technical assistance to authorizing authorities to obtain related market authorizationindustrial research and analysis in the field of pharmaceuticals and active pharmaceutical ingredients; biological research services; chemical analysis; chemical researchchemistry servicessynthesis and manufacturing of active pharmaceutical ingredientsintermediates thereof and finished dosage formsfor pharmaceutical research use; analysis and quality control for others of pharmaceuticals and their manufacturing process; research and development of new pharmaceutical products for others

Classe 44

Medical services; veterinary services; hygienic and beauty care for human beings or animals; pharmacy advicemedical and pharmaceutical consultancy and assistance before authorizing authorities

Classe 45

Legal services and representationintellectual property consultancy; intellectual property licensing

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

NREP

NEW REPRESENTATIVE AT IB RECEIVED

16/05/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

06/09/2024

71AG

REGISTERED-SEC.71 ACCEPTED

06/09/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/09/2024

ES71

TEAS SECTION 71 RECEIVED

29/11/2023

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

24/04/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

19/04/2019

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

31/08/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/08/2018

FIMP

FINAL DISPOSITION PROCESSED

06/08/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

24/07/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

24/04/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/02/2018

PUBO

PUBLISHED FOR OPPOSITION

06/02/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

17/01/2018

RFNT

REFUSAL PROCESSED BY IB

06/01/2018

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

02/01/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

15/12/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

15/12/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

15/12/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

15/12/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

15/12/2017

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

27/11/2017

GNRT

NON-FINAL ACTION E-MAILED

27/11/2017

CNRT

NON-FINAL ACTION WRITTEN

27/11/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/11/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/11/2017

ALIE

ASSIGNED TO LIE

01/11/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/10/2017

RFNT

REFUSAL PROCESSED BY IB

30/09/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

14/09/2017

RFRR

REFUSAL PROCESSED BY MPU

14/09/2017

MAFR

APPLICATION FILING RECEIPT MAILED

12/09/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/09/2017

CNRT

NON-FINAL ACTION WRITTEN

10/09/2017

DOCK

ASSIGNED TO EXAMINER

06/09/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/09/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

31/08/2017

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace AZAD ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.